Cymbalta 30 mg Hard Gastric-Resistant Capsules
Cymbalta 60 mg Hard Gastric-Resistant Capsules
duloxetina (hydrochloride)
Read this entire leaflet carefully before you start taking this medicine because it contains important information for you.
1.What Cymbalta is and what it is used for
Cymbalta contains the active ingredient duloxetine. Cymbalta increases the levels of serotonin and norepinephrine in the nervous system.
Cymbalta is used in adults to treat:
Cymbalta begins to take effect in most people with depression or anxiety within two weeks of starting treatment, but it may take between 2 and 4 weeks to start feeling better. Inform your doctor if you do not notice improvement after this time. Your doctor may continue giving you Cymbalta when you are feeling better to prevent your depression or anxiety from returning.
In people with diabetic neuropathic pain, it may take several weeks to start feeling better. Consult your doctor if you do not feel better after 2 months.
Do not take Cymbalta if
Consult your doctor if you have high blood pressure or heart disease. Your doctor will tell you if you should take Cymbalta.
Cymbalta may not be suitable for you for the following reasons. Consult your doctor before taking Cymbalta if:
Cymbalta may cause a feeling of restlessness or inability to sit or stay still. If this happens, tell your doctor.
if you experience signs and symptoms of restlessness, hallucinations, loss of coordination, rapid heartbeat, increased body temperature, rapid changes in blood pressure, hyperactive reflexes, diarrhea, coma, nausea, vomiting, as you may be suffering from a serotonin syndrome.
In its most severe form, serotonin syndrome can resemble Neuroleptic Malignant Syndrome (NMS). The signs and symptoms of NMS may include a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased muscle enzymes (determined by blood tests).
Some medicines in the same group as Cymbalta (called SSRIs/SNRIs) may cause sexual dysfunction symptoms (see section 4). In some cases, these symptoms persist after stopping treatment.
If you are depressed or have anxiety disorders, you may occasionally have thoughts of self-harm or suicide. These thoughts may be increased at the beginning of treatment with antidepressants, as all these medicines take time to work, usually two weeks but sometimes longer.
It is more likely that you will have these thoughts if:
It may be helpful to tell a close friend or family member that you are depressed or have anxiety disorders, and ask them to read this leaflet. They may be able to tell you if your depression or anxiety is getting worse, or if they are concerned about changes in your behaviour.
Cymbalta is usually not used in children and adolescents under 18 years old. You should also know that patients under 18 years old who take this type of medicine have an increased risk of side effects such as suicidal thoughts, suicidal behaviour, and hostility (mainly aggression, oppositional behaviour, and irritability). Despite this, your doctor may prescribe Cymbalta to patients under 18 years old because they decide it may be beneficial for the patient. If your doctor has prescribed Cymbalta to a patient under 18 years old andyou want to talk about it, please go back to the doctor. You should inform your doctor if any of the symptoms mentioned above appear or worsen in patients under 18 years old who are taking Cymbalta. Additionally, in this age group, the long-term safety effects of Cymbalta related to growth, maturation, and cognitive and behavioural development have not yet been demonstrated.
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine, including those bought without a prescription.
The main component of Cymbalta, duloxetine, is used in other medicines for other treatments:
It should be avoided to use more than one of these medicines at the same time. Check with your doctor if you are already using other medicines that contain duloxetine.
Your doctor will decide if you can take Cymbalta with other medicines.Do not start or stop taking any medicine, including those bought without a prescription, without first consulting your doctor.
You should also inform your doctor if you are taking any of the following medicines:
Monoamine oxidase inhibitors (MAOIs):Do not take Cymbalta if you are taking, or have taken in the last 14 days, another antidepressant known as a monoamine oxidase inhibitor (MAOI). As examples of MAOIs, moclobemide (an antidepressant) and linezolid (an antibiotic) are included. Taking an MAOI with many prescription medicines, including Cymbalta, may cause serious side effects, even life-threatening. You should wait at least 14 days after stopping treatment with an MAOI before taking Cymbalta. Similarly, you should wait at least 5 days after stopping treatment with Cymbalta before starting treatment with an MAOI.
Medicines that cause drowsiness:This includes prescription medicines prescribed by your doctor, such as benzodiazepines, powerful analgesics, antipsychotics, phenobarbital, and antihistamines.
Medicines that increase serotonin levels:Triptans, tramadol,tryptophan, selective serotonin reuptake inhibitors (SSRIs, such as paroxetine and fluoxetine), serotonin-norepinephrine reuptake inhibitors (SNRIs, such as venlafaxine),tricyclic antidepressants (such as clomipramine, amitriptyline), petidin, St. John's Wort, and MAOIs (such as moclobemide and linezolid). These medicines increase the risk of side effects; if you observe any unusual symptoms when using any of these medicines with Cymbalta, you should inform your doctor.
Oral anticoagulants or antiplatelet agents:Medicines that thin the blood or prevent the formation of blood clots. These medicines may increase the risk of bleeding.
Cymbalta can be taken with or without food. You should be careful if you take alcohol while taking Cymbalta.
If you are pregnant or breastfeeding, consult your doctor or pharmacist before using this medicine.
During treatment with Cymbalta, you may feel drowsy or dizzy. Do not drive or operate tools or machinery until you know how Cymbalta affects you.
Cymbalta containssaccharose.If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per capsule; this is, essentially "sodium-free".
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Cymbalta should be taken orally. Swallow the entire capsule with water.
For depression and diabetic neuropathic pain:
The recommended dose of Cymbalta is 60 mg once a day, but your doctor will prescribe the dose that is best for you.
For generalized anxiety disorder:
The usual starting dose of Cymbalta is 30 mg once a day, after which most patients will receive 60 mg once a day, but your doctor will prescribe the dose that is best for you. The dose can be adjusted up to 120 mg per day depending on your response to Cymbalta.
To avoid forgetting to take Cymbalta, it may be helpful to take it at the same time every day.
Discuss with your doctor for how long you should take Cymbalta. Do not stop taking Cymbalta, or change your dose without consulting your doctor. It is essential to treat your condition properly to help you improve.If you do not treat it, your condition may not disappear and may become more severe and harder to treat.
Call your doctor or pharmacist immediately if you take more Cymbalta than prescribed by your doctor. Symptoms of an overdose include drowsiness, coma, serotonin syndrome (a rare reaction that can cause intense feelings of happiness, drowsiness, clumsiness, restlessness, feeling drunk, fever, sweating, or muscle stiffness), seizures, vomiting, and high heart rate.
If you forget to take a dose, take it as soon as you remember. However, if it is time for your next dose, skip the missed dose and take a single dose as you normally do. Do not take a double dose to make up for the missed doses. Do not take more Cymbalta than prescribed for you in a day.
DO NOT stop taking your capsules without consulting your doctor even if you feel better. If your doctor thinks you no longer need to take Cymbalta, they will instruct you to reduce your dose for at least 2 weeks before stopping treatment.
Some patients who suddenly stopped treatment with Cymbalta have experienced symptoms such as:
These symptoms are usually not significant and disappear within a few days, but if you have symptoms that are bothersome, ask your doctor for advice.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them. These side effects are usually mild to moderate and often disappear within a few weeks.
tingling sensation in the skin
Children and adolescents under 18 years of age with depression treated with this medicine experienced a decrease in weight when they started taking this medicine. After 6 months of treatment, the weight increased to similar levels as other children and adolescents of the same age and sex.
If you experience any type of side effect,consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through thenational reporting system included in theAppendix V. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging.
Store in the original packaging to protect it from moisture. Do not store at a temperature above 30°C.
Medications should not be disposed of through drains or trash.Ask your pharmacist how to dispose of the packaging and medications that you no longer need. This will help protect the environment.
Composition of Cymbalta
The active ingredient is duloxetine.
Each capsule contains 30 or 60 mg of duloxetine (as hydrochloride).
The other components are:
Capule content: hypromellose, acetate succinate of hypromellose, sucrose, sugar spheres, talc, titanium dioxide (E171), and triethyl citrate (For more information on sucrose, see the end of section 2).
Capule body: gelatin, sodium lauryl sulfate, titanium dioxide (E171), indigo carmine (E132), yellow iron oxide (E172) (only 60 mg), and edible green ink (30 mg) or edible white ink (60 mg).
Edible green ink: synthetic black iron oxide (E172), synthetic yellow iron oxide (E172), propylene glycol, and shellac.
Edible white ink: titanium dioxide (E171), propylene glycol, shellac, and povidone.
Cymbalta is a hard, gastro-resistant capsule. Each Cymbalta capsule contains pellets of duloxetine hydrochloride with a coating to protect them from stomach acid.
Cymbalta is available in two doses: 30 mg and 60 mg.
The 30 mg capsules are blue and white and have "30 mg" and the code "9543" printed on them. The 60 mg capsules are blue and green and have "60 mg" and the code "9542" printed on them.
Cymbalta 30 mg is available in packages of 7, 28, and 98 hard, gastro-resistant capsules. Cymbalta 60 mg is available in packages of 28, 56, 84, and 98 hard, gastro-resistant capsules and in multi-pack containers containing 100 (5 packages of 20) and 500 (25 packages of 20) hard, gastro-resistant capsules.
Only some package sizes may be marketed.
Marketing authorization holder: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Netherlands.
Responsible manufacturer: Lilly S.A., Avda. de la Industria, 30, 28108 Alcobendas, Madrid, Spain.
For more information about this medicine, please contact the local representative of the marketing authorization holder:
België/Belgique/Belgien Eli Lilly Benelux S.A./N.V. Tél/Tel: + 32-(0)2 548 84 84 | Lietuva Eli Lilly Lietuva Tel. +370 (5) 2649600 |
Luxembourg/Luxemburg Eli Lilly Benelux S.A./N.V. Tél/Tel: + 32-(0)2 548 84 84 | |
Ceská republika ELI LILLY CR, s.r.o. Tel: + 420 234 664 111 | Magyarország Lilly Hungária Kft. Tel: + 36 1 328 5100 |
Danmark Eli Lilly Danmark A/S Tlf: +45 45 26 60 00 Deutschland Lilly Deutschland GmbH Tel. + 49-(0) 6172 273 2222 Nederland Eli Lilly Nederland B.V. Tel: + 31-(0) 30 60 25 800 Norge Eli Lilly Norge A.S. Tlf: + 47 22 88 18 00 España Dista S.A. Tel: + 34-91-663 50 00 France Lilly France Tél: +33-(0) 1 55 49 34 34 Hrvatska Eli Lilly Hrvatska d.o.o. Tel: +385 1 2350 999 Ireland Eli Lilly and Company (Ireland) Limited Tel: + 353-(0) 1 661 4377 Ísland Icepharma hf. Sími + 354 540 8000 Italia Eli Lilly Italia S.p.A. Tel: + 39- 055 42571 | Malta Charles de Giorgio Ltd. Tel: + 356 25600 500 Eesti Eli Lilly Nederland B.V. Tel: +372 6 817 280 Ελλάδα ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ Α.Ε.Β.Ε. Τηλ: +30 210 629 4600 Österreich Eli Lilly Ges.m.b.H. Tel: + 43-(0) 1 711 780 Polska Eli Lilly Polska Sp. z o.o. Tel: +48 22 440 33 00 Portugal Lilly Portugal Produtos Farmacêuticos, Lda Tel: + 351-21-4126600 Ro mânia Eli Lilly România S.R.L. Tel: + 40 21 4023000 Slovenija Eli Lilly farmacevtska družba, d.o.o. Tel: +386 (0)1 580 00 10 Slovenská republika Eli Lilly Slovakia s.r.o. Tel: + 421 220 663 111 Suomi/Finland Oy Eli Lilly Finland Ab Puh/Tel: + 358-(0) 9 85 45 250 |
Κύπρος Phadisco Ltd Tηλ: +357 22 715000 Latvija Eli Lilly (Suisse) S.A Parstavnieciba Latvija Tel: +371 67364000 | Sverige Eli Lilly Sweden AB Tel: + 46-(0) 8 7378800 United Kingdom (Northern Ireland) Eli Lilly and Company (Ireland) Limited Tel: + 353-(0) 1 661 4377 |
Date of the last revision of this prospectus:
The detailed information about this medicine is available on the website of the European Medicines Agency: https : // www . ema . europa . eu .
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.